Skip to main content

Patient Engagement

By Rachel McArthur | 05:03 am | January 21, 2021
There are four main types of vaccines currently approved, in approval or being considered in the MENA region in its fight against COVID-19. We bring you a summary of just what they are, how they differ, along with the advantages and disadvantages of each type.
By Sophie Porter | 03:15 am | January 20, 2021
NHSX develops national imaging database to identify patterns and variations of COVID-19 in UK patients..
By Charles Alessi | 02:55 am | January 20, 2021
We are witnessing a race in the vaccine rollout. A race towards the light at the end of a tunnel and a race which will likely define the next few years, according to Dr Charles Alessi, chief clinical officer at HIMSS. 
SPONSORED
By Salesforce | 05:41 pm | January 15, 2021
While the pandemic has accelerated the adoption of digital tools, it’s an important time to reassess them for long-term success.
By Kat Jercich | 03:18 pm | January 15, 2021
Accolade intends to strengthen its ability to provide users with second opinions, using 2nd.MD's provider network.
By Kat Jercich | 11:25 am | January 15, 2021
A JAMA Network study found that medical oncology professionals had conflicting opinions regarding the barriers to and benefits of video visits.
By Mike Miliard | 10:39 am | January 15, 2021
The web-based Quick Vaccination tool enables customers to more easily administer the vaccine at multiple locations, and generates a certificate that's viewable in the patient portal.
By Sophie Porter | 02:31 am | January 15, 2021
The prototype, jointly developed by Mvine and iProov and backed by Innovate UK, proves immunity status without disclosing the user’s identity.
By Mike Miliard | 10:51 am | January 14, 2021
The new coalition, which also includes Carin Alliance, Mayo Clinic, Microsoft and Salesforce, is using FHIR standards to enable more secure, interoperable access to digital vaccination records.
By Kat Jercich | 10:45 am | January 14, 2021
In lieu of a federal vaccine management system – at least for now – states have turned to their own technology for allocating and tracking the COVID-19 vaccine.